Evaluation of efficiency of mesenteric approach during pancreaticoduodenectomy for pancreatic cancer

Evaluation of efficiency of mesenteric approach during pancreaticoduodenectomy for pancreatic cancer - Evaluation of efficiency of mesenteric approach during pancreaticoduodenectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026220

Enrollment

237

Registered

2017-02-20

Start date

2017-01-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with pancreatic ductal adenocarcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: pancreatic cancer patients undergoing pancreaticoduodenectomy

Exclusion criteria

Exclusion criteria: patients without pathological diagnosis of pancreatic ductal adenocarcinoma

Design outcomes

Primary

Measure	Time frame
Blood loss volume, R0 rate	—

Secondary

Measure	Time frame
operative time, recurrence rate, overall survival, disease free survival	—

Countries

Japan

Contacts

Public ContactSeiko Hirono

Wakayama Medical University Second Department of Surgery

seiko-h@wakayama-med.ac.jp073-441-0613

Outcome results